Second-Generation Antipsychotics

Michael M. Morgan; MacDonald J. Christie; Luı́s de Lecea; Jason C. G. Halford; Josée E. Leysen; Warren H. Meck; Catalin V. Buhusi; Marcy J. Bubar; Kathryn A. Cunningham; Marcy J. Bubar; Kathryn A. Cunningham; Richard W. Foltin; David C. S. Roberts; Andreas Marneros; Andreas Marneros; Alex Hofer; Bart Ellenbroek; Christoph U. Correll; Paul Newhouse; Heather Wilkins; Bart Ellenbroek; Joris C. Verster; Emma Childs; Gary Remington; Edoardo Spina; W. Wolfgang Fleischhacker; John Atack; Hilde Lavreysen; David C. S. Roberts; Sheldon Preskorn; Megan M. Dahmen; Jana Lincoln; Dan Joseph Stein; Anthony L. Riley; Steve Kohut; Angela Roberts; Marilyn E. Carroll; Peter A. Santi; Stefan Leucht; Klaus A. Miczek; David C. S. Roberts; Eileen M. Joyce; Jonathan P. Roiser; Celia J. A. Morgan; Valerie H. Curran; Mary E. Cain; Michael T. Bardo; Terry E. Robinson; Ian Hindmarch; Marilyn E. Carroll; Peter A. Santi; Marcy J. Bubar; Kathryn A. Cunningham; Darrell D. Mousseau; Andrew Holt; Glen B. Baker; Sidney H. Kennedy; Sakina J. Rizvi; Thomas Steckler; Klaus A. Miczek; Seiya Miyamoto; Şakire Pöğün; Görkem Yararbaş; Jill B. Becker; Anders Ågmo; Vera Astreika; Robert Segraves; Rodrigo Andrade; Yogita Chudasama; Roshan Cools; Iván Izquierdo; Lia R. Bevilaqua; Martı́n Cammarota; Bernard Le Foll; Trevor W. Robbins; Husseini K. Manji; Jorge A. Quiroz; Jos Prickaerts; Bart Ellenbroek; Ennio Esposito; Roberto William Invernizzi; Sophie Tambour; John C. Crabbe; Peter J. Flor; Inga D. Neumann; Malcolm Lader; Joseph Zohar; Seithikurippu R. Pandi‐Perumal; Milton Kramer; Michael J. Thorpy; Shelby Freedman Harris; D. Warren Spence; Gabriele Fischer; Annemarie Unger; Samuel B. Hutton; Huaiyu Yang; George I. Papakostas; S. Kasper; Frank Sams‐Dodd; Yavin Shaham

doi:10.1007/978-3-540-68706-1_1057

Chapter in a book2010

Second and Third Generation Antipsychotics

Michael M. Morgan, MacDonald J. Christie, Luı́s de Lecea, Jason C. G. Halford, Josée E. Leysen, Warren H. Meck, Catalin V. Buhusi, Marcy J. Bubar, Kathryn A. Cunningham, Marcy J. Bubar, Kathryn A. Cunningham, Richard W. Foltin, David C. S. Roberts, Andreas Marneros, Andreas Marneros, Alex Hofer, Bart Ellenbroek, Christoph U. Correll, Paul Newhouse, Heather Wilkins, Bart Ellenbroek, Joris C. Verster, Emma Childs, Gary Remington, Edoardo Spina, W. Wolfgang Fleischhacker, John Atack, Hilde Lavreysen, David C. S. Roberts, Sheldon Preskorn, Megan M. Dahmen, Jana Lincoln, Dan Joseph Stein, Anthony L. Riley, Steve Kohut, Angela Roberts, Marilyn E. Carroll, Peter A. Santi, Stefan Leucht, Klaus A. Miczek, David C. S. Roberts, Eileen M. Joyce, Jonathan P. Roiser, Celia J. A. Morgan, Valerie H. Curran, Mary E. Cain, Michael T. Bardo, Terry E. Robinson, Ian Hindmarch, Marilyn E. Carroll, Peter A. Santi, Marcy J. Bubar, Kathryn A. Cunningham, Darrell D. Mousseau, Andrew Holt, Glen B. Baker, Sidney H. Kennedy, Sakina J. Rizvi, Thomas Steckler, Klaus A. Miczek, Seiya Miyamoto, Şakire Pöğün, Görkem Yararbaş, Jill B. Becker, Anders Ågmo, Vera Astreika, Robert Segraves, Rodrigo Andrade, Yogita Chudasama, Roshan Cools, Iván Izquierdo, Lia R. Bevilaqua, Martı́n Cammarota, Bernard Le Foll, Trevor W. Robbins, Husseini K. Manji, Jorge A. Quiroz, Jos Prickaerts, Bart Ellenbroek, Ennio Esposito, Roberto William Invernizzi, Sophie Tambour, John C. Crabbe, Peter J. Flor, Inga D. Neumann, Malcolm Lader, Joseph Zohar, Seithikurippu R. Pandi‐Perumal, Milton Kramer, Michael J. Thorpy, Shelby Freedman Harris, D. Warren Spence, Gabriele Fischer, Annemarie Unger, Samuel B. Hutton, Huaiyu Yang, George I. Papakostas, S. Kasper, Frank Sams‐Dodd, Yavin Shaham

Article2018

Second-generation antipsychotics and metabolic side-effects: Canadian population-based study

Lauren Hirsch, Scott Burton Patten, Lauren Bresee, Nathalie Jetté, Tamara Pringsheim

Article2012

Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol

José Manuel Goikolea, Francesc Colom, Imma Torres, Jorge Capapey, Marc Valentí, Juan Undurraga, Iría Grande, José Sánchez‐Moreno, Eduard Vieta

Article2017

Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review

Marco Solmi, Andréa Murru, Isabella Pacchiarotti, Juan Undurraga, Nicola Veronese, Michele Fornaro, Brendon Stubbs, Francesco Monaco, Eduard Vieta, Mary V. Seeman, Christoph U. Correll, André F. Carvalho

Chapter in a book2010

Second-Generation Anticonvulsants

Michael M. Morgan, MacDonald J. Christie, Luı́s de Lecea, Jason C. G. Halford, Josée E. Leysen, Warren H. Meck, Catalin V. Buhusi, Marcy J. Bubar, Kathryn A. Cunningham, Marcy J. Bubar, Kathryn A. Cunningham, Richard W. Foltin, David C. S. Roberts, Andreas Marneros, Andreas Marneros, Alex Hofer, Bart Ellenbroek, Christoph U. Correll, Paul Newhouse, Heather Wilkins, Bart Ellenbroek, Joris C. Verster, Emma Childs, Gary Remington, Edoardo Spina, W. Wolfgang Fleischhacker,

Second-Generation Antipsychotics

Discussion(0)

Related publications

Second and Third Generation Antipsychotics

Second-generation antipsychotics and metabolic side-effects: Canadian population-based study

Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol

Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review

Second-Generation Anticonvulsants